Concepts (149)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Patient Admission | 4 | 2023 | 185 | 0.440 |
Why?
|
| Bronchiolitis, Viral | 3 | 2011 | 29 | 0.440 |
Why?
|
| Asthma | 4 | 2013 | 921 | 0.440 |
Why?
|
| Hypotonic Solutions | 1 | 2014 | 11 | 0.420 |
Why?
|
| Isotonic Solutions | 1 | 2014 | 37 | 0.410 |
Why?
|
| Respiratory Syncytial Virus Infections | 5 | 2011 | 395 | 0.400 |
Why?
|
| Child, Hospitalized | 1 | 2014 | 77 | 0.390 |
Why?
|
| Hyponatremia | 1 | 2014 | 71 | 0.390 |
Why?
|
| Fluid Therapy | 1 | 2014 | 146 | 0.380 |
Why?
|
| Triage | 3 | 2023 | 143 | 0.320 |
Why?
|
| Apnea | 1 | 2009 | 26 | 0.300 |
Why?
|
| Intensive Care Units, Pediatric | 3 | 2019 | 493 | 0.250 |
Why?
|
| Critical Care | 3 | 2022 | 684 | 0.230 |
Why?
|
| Patient Discharge | 2 | 2019 | 511 | 0.230 |
Why?
|
| Nystagmus, Congenital | 1 | 2004 | 1 | 0.220 |
Why?
|
| Albinism, Oculocutaneous | 1 | 2004 | 2 | 0.220 |
Why?
|
| Bronchiolitis | 3 | 2015 | 126 | 0.220 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2026 | 143 | 0.220 |
Why?
|
| B7-H1 Antigen | 1 | 2026 | 130 | 0.220 |
Why?
|
| Oculomotor Muscles | 1 | 2004 | 79 | 0.210 |
Why?
|
| Infant, Premature | 1 | 2009 | 857 | 0.200 |
Why?
|
| Hospitalization | 5 | 2023 | 1928 | 0.200 |
Why?
|
| Pneumonia | 2 | 2018 | 340 | 0.190 |
Why?
|
| Hospitalists | 1 | 2022 | 53 | 0.170 |
Why?
|
| Pediatrics | 2 | 2022 | 1243 | 0.170 |
Why?
|
| Hospitals | 1 | 2023 | 437 | 0.160 |
Why?
|
| Length of Stay | 2 | 2015 | 1398 | 0.150 |
Why?
|
| Child | 12 | 2023 | 26097 | 0.140 |
Why?
|
| Diabetes Mellitus | 1 | 2026 | 889 | 0.130 |
Why?
|
| Community-Acquired Infections | 2 | 2018 | 252 | 0.120 |
Why?
|
| Continuity of Patient Care | 1 | 2018 | 143 | 0.120 |
Why?
|
| Period Circadian Proteins | 1 | 2015 | 25 | 0.120 |
Why?
|
| United States | 6 | 2026 | 11859 | 0.110 |
Why?
|
| Bacterial Typing Techniques | 1 | 2015 | 97 | 0.110 |
Why?
|
| Oximetry | 1 | 2015 | 176 | 0.110 |
Why?
|
| Severity of Illness Index | 4 | 2013 | 3031 | 0.110 |
Why?
|
| Infant | 10 | 2019 | 13239 | 0.100 |
Why?
|
| Monitoring, Physiologic | 1 | 2015 | 369 | 0.100 |
Why?
|
| Mycoplasma pneumoniae | 1 | 2013 | 13 | 0.100 |
Why?
|
| Nebulizers and Vaporizers | 2 | 2010 | 60 | 0.100 |
Why?
|
| Humans | 21 | 2026 | 130342 | 0.090 |
Why?
|
| Infusions, Intravenous | 1 | 2014 | 535 | 0.090 |
Why?
|
| Attitude of Health Personnel | 1 | 2018 | 704 | 0.090 |
Why?
|
| Risk Assessment | 2 | 2014 | 3672 | 0.090 |
Why?
|
| Child, Preschool | 7 | 2018 | 14949 | 0.090 |
Why?
|
| Bacterial Toxins | 1 | 2013 | 170 | 0.090 |
Why?
|
| Risk | 1 | 2014 | 722 | 0.090 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2018 | 773 | 0.090 |
Why?
|
| Health Status | 1 | 2013 | 372 | 0.080 |
Why?
|
| Neoplasms | 1 | 2026 | 2960 | 0.080 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2010 | 21 | 0.080 |
Why?
|
| Cohort Studies | 4 | 2018 | 5047 | 0.080 |
Why?
|
| Feeding Behavior | 1 | 2015 | 708 | 0.080 |
Why?
|
| Drosophila melanogaster | 1 | 2015 | 837 | 0.080 |
Why?
|
| Drosophila Proteins | 1 | 2015 | 776 | 0.080 |
Why?
|
| Vocal Cords | 1 | 2009 | 61 | 0.070 |
Why?
|
| Forced Expiratory Volume | 1 | 2009 | 178 | 0.070 |
Why?
|
| Environment | 1 | 2009 | 149 | 0.070 |
Why?
|
| Cough | 1 | 2009 | 98 | 0.070 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2009 | 93 | 0.070 |
Why?
|
| Bacterial Infections | 1 | 2011 | 324 | 0.070 |
Why?
|
| Delphi Technique | 2 | 2019 | 270 | 0.070 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2009 | 134 | 0.070 |
Why?
|
| Bacterial Proteins | 1 | 2013 | 940 | 0.070 |
Why?
|
| Cost of Illness | 1 | 2009 | 293 | 0.060 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2009 | 333 | 0.060 |
Why?
|
| Allergens | 1 | 2009 | 344 | 0.060 |
Why?
|
| Environmental Exposure | 1 | 2009 | 289 | 0.060 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2009 | 345 | 0.060 |
Why?
|
| Quality of Life | 2 | 2013 | 2081 | 0.060 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2026 | 40 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 2562 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2009 | 1481 | 0.060 |
Why?
|
| Combined Modality Therapy | 1 | 2009 | 1217 | 0.060 |
Why?
|
| Adolescent | 6 | 2023 | 20718 | 0.060 |
Why?
|
| Physician-Patient Relations | 1 | 2009 | 436 | 0.060 |
Why?
|
| Male | 11 | 2026 | 64409 | 0.060 |
Why?
|
| Macrophage Inflammatory Proteins | 2 | 2005 | 10 | 0.060 |
Why?
|
| Female | 11 | 2026 | 70331 | 0.050 |
Why?
|
| Head Movements | 1 | 2004 | 18 | 0.050 |
Why?
|
| Eye Movements | 1 | 2004 | 68 | 0.050 |
Why?
|
| Posture | 1 | 2004 | 135 | 0.050 |
Why?
|
| Electrophysiology | 1 | 2004 | 249 | 0.050 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 2004 | 90 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2009 | 1877 | 0.050 |
Why?
|
| Interleukin-18 | 1 | 2004 | 75 | 0.050 |
Why?
|
| Interleukin-12 | 1 | 2004 | 124 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2015 | 4669 | 0.050 |
Why?
|
| Infant, Newborn | 4 | 2011 | 8532 | 0.050 |
Why?
|
| Patient Acuity | 1 | 2023 | 66 | 0.050 |
Why?
|
| Prevalence | 1 | 2009 | 2687 | 0.050 |
Why?
|
| Emergency Service, Hospital | 2 | 2023 | 1216 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 2 | 2019 | 1288 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2004 | 550 | 0.040 |
Why?
|
| Syndrome | 1 | 2004 | 1159 | 0.040 |
Why?
|
| Incidence | 1 | 2009 | 3316 | 0.040 |
Why?
|
| Visual Acuity | 1 | 2004 | 531 | 0.040 |
Why?
|
| Respiratory Tract Infections | 1 | 2004 | 297 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2026 | 1122 | 0.040 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2001 | 153 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2009 | 5162 | 0.040 |
Why?
|
| Inservice Training | 1 | 2019 | 55 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2013 | 6438 | 0.040 |
Why?
|
| Advisory Committees | 1 | 2019 | 148 | 0.040 |
Why?
|
| Influenza, Human | 1 | 2005 | 702 | 0.030 |
Why?
|
| Patient Transfer | 1 | 2019 | 109 | 0.030 |
Why?
|
| Stakeholder Participation | 1 | 2018 | 35 | 0.030 |
Why?
|
| Hospitals, Community | 1 | 2018 | 51 | 0.030 |
Why?
|
| Oxygen | 2 | 2015 | 553 | 0.030 |
Why?
|
| Retrospective Studies | 4 | 2019 | 17516 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 684 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2015 | 32 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2019 | 558 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2015 | 175 | 0.030 |
Why?
|
| Risk Factors | 1 | 2009 | 10941 | 0.030 |
Why?
|
| Multiprotein Complexes | 1 | 2015 | 196 | 0.030 |
Why?
|
| Demography | 1 | 2015 | 236 | 0.030 |
Why?
|
| Sirolimus | 1 | 2015 | 231 | 0.030 |
Why?
|
| Chemokine CCL4 | 2 | 2005 | 13 | 0.020 |
Why?
|
| Chemokine CCL3 | 2 | 2005 | 17 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2015 | 430 | 0.020 |
Why?
|
| Amino Acids | 1 | 2015 | 561 | 0.020 |
Why?
|
| Hospitals, Pediatric | 1 | 2018 | 798 | 0.020 |
Why?
|
| Chemokine CCL2 | 2 | 2005 | 112 | 0.020 |
Why?
|
| Breath Tests | 1 | 2013 | 182 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2013 | 211 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2015 | 1572 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 1074 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2015 | 1210 | 0.020 |
Why?
|
| Bacteria | 1 | 2015 | 519 | 0.020 |
Why?
|
| Meningitis, Bacterial | 1 | 2011 | 98 | 0.020 |
Why?
|
| Logistic Models | 1 | 2015 | 1799 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2013 | 792 | 0.020 |
Why?
|
| Sex Factors | 1 | 2013 | 1339 | 0.020 |
Why?
|
| Aged | 1 | 2026 | 20859 | 0.020 |
Why?
|
| Caregivers | 1 | 2013 | 576 | 0.020 |
Why?
|
| Bacteremia | 1 | 2011 | 428 | 0.020 |
Why?
|
| Urinary Tract Infections | 1 | 2011 | 327 | 0.020 |
Why?
|
| Middle Aged | 1 | 2026 | 28366 | 0.010 |
Why?
|
| Chemokine CCL5 | 1 | 2005 | 53 | 0.010 |
Why?
|
| Exudates and Transudates | 1 | 2004 | 15 | 0.010 |
Why?
|
| Adult | 1 | 2004 | 31121 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2013 | 4027 | 0.010 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2004 | 241 | 0.010 |
Why?
|
| Nasopharynx | 1 | 2001 | 86 | 0.010 |
Why?
|
| Th1 Cells | 1 | 2001 | 159 | 0.010 |
Why?
|
| Th2 Cells | 1 | 2001 | 188 | 0.010 |
Why?
|
| Cytokines | 1 | 2001 | 1343 | 0.010 |
Why?
|
| Animals | 1 | 2015 | 33796 | 0.010 |
Why?
|